文献速递血液净化与透析肾移植

需要维持性透析的婴儿:血液透析与腹膜透析的结局

Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis.
PubMed 文献 · Am J Kidney Dis · 2016-12-10

基于ESPN/ERA-EDTA登记库1991至2013年1,063例12月龄及以下开始透析的婴儿,比较腹膜透析(917例)与血液透析(146例)的患者生存、技术生存和肾移植可及性。两组死亡风险和移植可能性相当,但血液透析组更换透析方式的风险更高(校正HR 1.64)。

要点

  • 在1,063例婴儿中,917例起始腹膜透析、146例起始血液透析。
  • 腹膜透析组与血液透析组死亡风险和移植可能性相当。
  • 血液透析组更换透析治疗的风险高于腹膜透析组(校正HR 1.64,95%CI 1.17-2.31)。

核心结论

  • 尽管普遍认为血液透析应保留用于腹膜透析不可行的病例,但在欧洲,每8例需要维持性透析的婴儿中就有1例起始血液透析治疗。
  • 起始腹膜透析与起始血液透析的婴儿在透析起始时特征、前瞻性生存和至移植时间方面非常相似。

研究设计与样本

  • 队列研究,数据提取自ESPN/ERA-EDTA登记库。
  • 纳入1991至2013年起始透析治疗的12月龄及以下婴儿1,063例。
  • 比较腹膜透析(917例)与血液透析(146例)的患者生存、技术生存和肾移植可及性,采用Cox回归分析校正透析起始年龄、性别、基础肾病和居住国家。

主要发现

  • 透析起始中位年龄4.5(IQR 0.7-7.9)月,中位体重5.7(IQR 3.7-7.5)kg。
  • 腹膜透析组先天性肾脏和尿路畸形(CAKUT)比例高于血液透析组(48% vs 27%),血液透析组代谢性疾病比例高于腹膜透析组(12% vs 4%)。
  • 死亡风险因素包括透析起始年龄较小(每推迟1个月起始的HR 0.95,95%CI 0.90-0.97)和非CAKUT病因的慢性肾衰竭(HR 1.49,95%CI 1.08-2.04)。
  • 腹膜透析与血液透析患者的死亡风险和移植可能性相当,血液透析患者更换透析治疗的风险更高(校正HR 1.64,95%CI 1.17-2.31)。

局限性

  • 无法控制登记数据库中未包含的未测量混杂因素。
  • 存在缺失数据(即合并症情况)。
  • 由于参与者数量相对较少,统计效能低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of different dialysis modalities on clinical outcomes has not been explored in young infants with chronic kidney failure. STUDY DESIGN: Cohort study. SETTING & PARTICIPANTS: Data were extracted from the ESPN/ERA-EDTA Registry. This analysis included 1,063 infants 12 months or younger who initiated dialysis therapy in 1991 to 2013. FACTOR: Type of dialysis modality. OUTCOMES & MEASUREMENTS: Differences between infants treated with peritoneal dialysis (PD) or hemodialysis (HD) in patient survival, technique survival, and access to kidney transplantation were examined using Cox regression analysis while adjusting for age at dialysis therapy initiation, sex, underlying kidney disease, and country of residence. RESULTS: 917 infants initiated dialysis therapy on PD, and 146, on HD. Median age at dialysis therapy initiation was 4.5 (IQR, 0.7-7.9) months, and median body weight was 5.7 (IQR, 3.7-7.5) kg. Although the groups were homogeneous regarding age and sex, infants treated with PD more often had congenital anomalies of the kidney and urinary tract (CAKUT; 48% vs 27%), whereas those on HD therapy more frequently had metabolic disorders (12% vs 4%). Risk factors for death were younger age at dialysis therapy initiation (HR per each 1-month later initiation, 0.95; 95% CI, 0.90-0.97) and non-CAKUT cause of chronic kidney failure (HR, 1.49; 95% CI, 1.08-2.04). Mortality risk and likelihood of transplantation were equal in PD and HD patients, whereas HD patients had a higher risk for changing dialysis treatment (adjusted HR, 1.64; 95% CI, 1.17-2.31). LIMITATIONS: Inability to control for unmeasured confounders not included in the Registry database and missing data (ie, comorbid conditions). Low statistical power because of relatively small number of participants. CONCLUSIONS: Despite a widespread preconception that HD should be reserved for cases in which PD is not feasible, in Europe, we found 1 in 8 infants in need of maintenance dialysis to be initiated on HD therapy. Patient characteristics at dialysis therapy initiation, prospective survival, and time to transplantation were very similar for infants initiated on PD or HD therapy.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Vidal E, van Stralen KJ, Chesnaye NC, et al. Infants Requiring Maintenance Dialysis: Outcomes of Hemodialysis and Peritoneal Dialysis. Am J Kidney Dis. 2016. PMID: 27955924. doi:10.1053/j.ajkd.2016.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。